✦ LIBER ✦

WT1, p53 and hormone receptor expression in uterine serous carcinoma

✍ Scribed by Lynn Hirschowitz; Raji Ganesan; W Glenn McCluggage

Book ID: 108780790
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 397 KB
Volume: 55
Category: Article
ISSN: 0309-0167
DOI: 10.1111/j.1365-2559.2009.03390.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression and mutation analysis of the

Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma

✍ Stephanie A. King; Amy A. Adas; Virginia A. Livolsi; Hiroyuki Takahashi; Kian Be 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 950 KB

WT-1 assists in distinguishing ovarian f

WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma

✍ M Al-Hussaini; A Stockman; H Foster; W G McCluggage 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Coabnormal expression of cyclin D1 and p

Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas

✍ Toshio Nikaido; Shuan-fang Li; Tanri Shiozawa; Shingo Fujii 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

## Background: In the normal cell cycle, tumor suppressor gene products (p53) and cyclin (cyclin d1) cooperate. abnormalities in the cooperation of these factors may result in malignant transformation of the cell. mutant p53 protein overexpression is defined in many human cancers, including endomet

p53CM1 expression is not associated with

p53CM1 expression is not associated with prognosis in uterine cervical carcinoma

✍ Kuniyuki Oka; Takashi Nakano; Tatsuo Arai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Prognostic value of hormonal receptors,

Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma

✍ Adelaida García-Velasco; César Mendiola; Alfonso Sánchez-Muñoz; Claudio Ballestí 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 92 KB

p21/WAF1, p53 and PCNA expression and p5

p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma

✍ Lan Fang Qin; Irene O. L. Ng; Sheung T. Fan; Matthew Ng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 443 KB 👁 2 views

The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs